Roth Capital Comments on Aurora Cannabis Inc.’s Q1 2025 Earnings (TSE:ACB)

Aurora Cannabis Inc. (TSE:ACB) – Stock analysts at Roth Capital issued their Q1 2025 earnings per share estimates for Aurora Cannabis in a research note issued on Monday, June 24th. Roth Capital analyst W. Kirk anticipates that the company will post earnings per share of ($0.03) for the quarter. The consensus estimate for Aurora Cannabis’ current full-year earnings is ($0.22) per share. Roth Capital also issued estimates for Aurora Cannabis’ Q2 2025 earnings at $0.10 EPS, Q3 2025 earnings at ($0.13) EPS, Q4 2025 earnings at $0.22 EPS and FY2025 earnings at $0.16 EPS.

Separately, ATB Capital dropped their price target on Aurora Cannabis from C$12.50 to C$11.00 and set a “sector perform” rating on the stock in a research report on Friday, June 21st.

Aurora Cannabis Price Performance

Shares of TSE:ACB opened at C$6.51 on Thursday. The company has a market cap of C$355.06 million, a price-to-earnings ratio of -0.08 and a beta of 2.65. The business has a 50 day moving average price of C$8.77 and a 200 day moving average price of C$5.01. The company has a quick ratio of 2.48, a current ratio of 3.79 and a debt-to-equity ratio of 18.51. Aurora Cannabis has a twelve month low of C$3.84 and a twelve month high of C$15.50.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.